Millstone Evans Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Millstone Evans Group's LLY Position: Q2 2026 in Review
Millstone Evans Group increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $225K and bringing the position to 1,385 shares worth $1.66M. The position accounts for 0.9% of the portfolio, ranked #20.
Millstone Evans Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Millstone Evans Group held 1,385 shares of Eli Lilly worth $1.66M as of Q2 2026.
- Millstone Evans Group bought 220 Eli Lilly shares in Q2 2026, an estimated $225K.
- Eli Lilly made up 0.9% of Millstone Evans Group's portfolio in Q2 2026, its #20 holding.
- Millstone Evans Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.